Columbia Laboratories Will Present on September 6 at Stifel Nicolaus Healthcare Conference

Columbia Laboratories Will Present on September 6 at Stifel Nicolaus Healthcare Conference

Columbia Laboratories, Inc.Lawrence A. Gyenes, 973-486-8860Senior Vice President,CFO & TreasurerorThe Trout Group LLCSeth Lewis, 646-378-2952Vice President

Columbia Laboratories Inc. (Nasdaq: CBRX) announced today that Frank Condella, president and chief executive officer, will present at the Stifel Nicolaus 2012 Healthcare Conference. The presentation is scheduled as follows:

A replay of the webcast will be available approximately 24 hours after the presentation and archived for 30 days at the aforementioned URLs.

Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit .

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

The 100 largest companies trading on the London Stock Exchange have boosted the percentage of women on their boards, but has life sciences kept pace?

In this week's EuroBiotech Report, Bicycle lands Genentech collaboration, GSK inks COVOD-19 adjuvant deal and Grifols buys antibiotic assets.